09.09.2026, 17:46

Promomed launches flagship drug in Kazakhstan

MOSCOW. Sept 9 (Interfax) – Kazakhstan's Health Ministry has granted Promomed a registration certificate for its tirzepatide-based drug, used to treat type 2 diabetes and obesity, the Russian pharmaceutical company said.

To read the full news articles, Subscribe.